Tecentriq (atezolizumab) subcutaneous
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tecentriq (atezolizumab) subcutaneous, covering 2023-06-13 to 2023-06-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 3]